Solid Biosciences Inc. SLDB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $155.55M+10.9% | $140.33M+5.5% | $132.96M+9.5% | $121.43M+11.9% | $108.47M+12.5% | ||
| $40.91M+5.2% | $38.88M+5.8% | $36.74M+3.8% | $35.4M+2.8% | $34.45M+3.5% | ||
| $196.46M+9.6% | $179.21M+5.6% | $169.7M+8.2% | $156.82M+9.7% | $142.92M+10.2% | ||
| -$196.46M-9.6% | -$179.21M-5.6% | -$169.7M-8.2% | -$156.82M-9.7% | -$142.92M-10.2% | ||
| —— | -$208K-56.4% | -$133K-147% | $285K-8.9% | $313K-7.9% | ||
| $5.07M-3.8% | $5.27M— | —— | —— | —— | ||
| -$191.78M-10.0% | -$174.33M-4.3% | -$167.14M-8.5% | -$154.08M-10.3% | -$139.68M-12.0% | ||
| -$1.95+3.5% | -$2.02+19.5% | -$2.51+11.0% | -$2.82+6.3% | -$3.01+1.6% | ||
| -$194.84M-9.7% | -$177.57M-5.7% | -$168.04M-8.3% | -$155.14M-10.5% | -$140.38M-10.3% | ||
| -$196.46M-9.6% | -$179.21M-5.6% | -$169.7M-8.2% | -$156.82M-9.7% | -$142.92M-10.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Solid Biosciences Inc.'s revenue?
- Solid Biosciences Inc. (SLDB) generated $8.1M in revenue over the trailing twelve months, down 40.6% year over year.
- Is Solid Biosciences Inc. profitable?
- Solid Biosciences Inc. is not currently profitable: it reported a net loss of $191.8M over the trailing twelve months, a -1062.3% net margin.
- What is Solid Biosciences Inc.'s earnings per share?
- Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.95.
- Where does Solid Biosciences Inc.'s income statement data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
